Technology | March 17, 2008

Trellis-8 Infusion Catheter Busts DVT Clots

Bacchus Vascular Inc. has developed a catheter-based device, the Trellis-8 infusion catheter, which disperses thrombolytic solution directly into the clot of patients with deep vein thrombosis (DVT), is said to be safe and effective, according to data presented at the 33rd annual meeting of the Society of Interventional Radiology, held March 16, 2008.

The Trellis-8 infusion catheter is an alternatives to catheter-directed thrombolysis, which is sometimes used as an adjunct to anticoagulation in more severe DVT cases. The device is FDA approved for use in the peripheral vasculature and is more commonly used to treat peripheral arterial occlusions, and can reportedly help treat DVT.

Related Content

Reflow Medical's Wingman Crossing Catheter Receives FDA Clearance for Coronary Indication
News | Catheters | October 02, 2017
October 2, 2017 — Reflow Medical Inc. announced that the company has received 510(k) clearance from the U.S.
Roxwood Medical Announces Agreement With Abbott for U.S. Product Distribution
News | Catheters | August 09, 2017
Roxwood Medical Inc. recently announced it has entered into an exclusive agreement with Abbott for distribution of...
Teleflex, FDA 510k clearance, TrapLiner Catheter, U.S. launch
Technology | Catheters | March 02, 2017
Teleflex Inc. has announced 510(k) clearance by the U.S. Food and Drug Administration (FDA) and U.S. commercial launch...
Merit Medical Systems, SwiftNINJA Steerable Microcatheter, FDA 510(k) clearance
Technology | Catheters | November 09, 2016
November 9, 2016 — Merit Medical Systems Inc.
VentureMed Group, Flex Scoring Catheter, FDA approval, peripheral arterial disease, PAD, endovascular treatment
Technology | Catheters | July 13, 2016
July 13, 2016 — VentureMed Group Ltd., specializing in devices for the endovascular treatment of...
Roxwood Medical, MicroCross Catheter, full U.S. launch

Image courtesy of Roxwood Medical

Technology | Catheters | January 07, 2016
Roxwood Medical Inc. reported that more than 500 patients have been successfully treated as part of the initial limited...
Overlay Init